Skip to main content

Solventum Corp MedSurg revenue

  • SOLV · NYSE
  • Medical devices
  • Health Care Technology
  • S&P 500
$89.08+0.30%Close 13 Nov 2026

MedSurg revenue at Solventum Corp came to $1.2B for the quarter to 30 Sep 2026, up 0.4% from a year earlier.

As Solventum Corp reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 5 Nov 2026.

By quarter

$1.2BDec 2023$1.1BMar 2024$1.2BJun 2024$1.2BSep 2024$1.2BDec 2024$1.2BMar 2025$1.2BJun 2025$1.2BSep 2025$1.2BDec 2025$1.2BMar 2026$1.4BJun 2026$1.2BSep 2026
Solventum Corp MedSurg revenue, every reported period
Period endingMedSurg revenueChange on a yearFiled
30 Sep 2026$1.2Bup 0.4%5 Nov 2026
30 Jun 2026$1.4Bup 12.6%5 Aug 2026
31 Mar 2026$1.2Bup 6.7%5 May 2026
31 Dec 2025$1.2Bup 5.3%27 Feb 2026
30 Sep 2025$1.2Bup 2.0%6 Nov 2025
30 Jun 2025$1.2Bup 4.8%8 Aug 2025
31 Mar 2025$1.2Bup 3.4%9 May 2025
31 Dec 2024$1.2Bup 0.5%28 Feb 2025
30 Sep 2024$1.2Bup 0.2%8 Nov 2024
30 Jun 2024$1.2Bup 0.1%9 Aug 2024
31 Mar 2024$1.1Bdown 0.4%10 May 2024
31 Dec 2023$1.2B—28 Feb 2025
30 Sep 2023$1.2B—8 Nov 2024
30 Jun 2023$1.2B—9 Aug 2024
31 Mar 2023$1.1B—10 May 2024

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Solventum Corp: Organic growth (change on a year) · Cost of product revenue · Cost of software and rentals revenue · Infection Prevention and Surgical Solutions revenue · Advanced Wound Care revenue · Health Information Systems revenue · Dental Solutions revenue · financial statements

Every KPI and segment of SOLV, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.